head JofIMAB
Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski Publishing Ltd.
ISSN: 1312-773X (Online)
Issue: 2023, vol. 29, issue4
Subject Area: Medicine
DOI: 10.5272/jimab.2023294.5150
Published online: 09 October 2023

Case report
J of IMAB. 2023 Oct-Dec;29(4):5150-5153
Diana Paskaleva1ORCID logoCorresponding Autoremail, Vasilka Gyurova-Kancheva1ORCID logo, Slavka Kacarova2ORCID logo, Bozhidar Pilichev3ORCID logo, Okean Kostov1ORCID logo, Maria Bozhkova4ORCID logo, Dimitar Penkov5ORCID logo,
1)Department of Nursing Care, Faculty of Public Health, Medical University of Plovdiv, Bulgaria.
2)Unihospal Panaguirishte, Bulgaria.
3)Department of Oral Surgery, Faculty of Dental Medicine, Medical University of Plovdiv, Bulgaria.
4) Department of Rehabilitator, Medical College, Medical University of Plovdiv, Bulgaria
5) Department of Pharmaceutical Sciences, Faculty of Pharmacy, Medical University of Plovdiv, Bulgaria.

Background - hyperbaric oxygen therapy (HBOT) is a clinical method of treatment with oxygen while under increased atmospheric pressure. It has been proven as an independent therapeutic factor for a number of diseases, and in the case of COVID-19, its potential as an adjuvant therapy is still being studied. Case report – in the case of a 61-year-old man with severe pneumonia resulting from infection with COVID-19 and persisting hypoxemia and dyspnea after the acute phase. Prescribed continuous oxygenation in home conditions due to deteriorating general condition and quality of life. Undertaken additional hyperbaric oxygen therapy resulting in significant improvement after the 20th session. Conclusion - the connection between HBOT and improved paraclinical and imaging indicators, in this case, suggests conclusions of a therapeutic effect of HBOT in hypoxemia as a post-COVID symptom .

Keywords: hypoxemia, COVID-19, hyperbaric oxygen therapy, quality of life,

pdf - Download FULL TEXT /PDF 3464 KB/
Please cite this article as: Paskaleva D, Gyurova-Kancheva V, Kacarova S, Pilichev B, Kostov O, Bozhkova M, Penkov D. Hyperbaric oxygen therapy (HBOT) as the treatment of prolonged hypoxemia due to COVID-19. J of IMAB. 2023 Oct-Dec;29(4):5150-5153. [Crossref - 10.5272/jimab.2023294.5150]

Corresponding AutorCorrespondence to: Senior Assist. Prof. Diana Paskaleva, PhD, Department of Nursing care, Faculty of Public Health, Medical University - Plovdiv; 15А, Vasil Aprilov str., Plovdiv, Bulgaria; E-mail: paskaleva_1975@abv.bg

1. Bozov H, Asparuchova M. An application of HBO in CO intoxication. A social and economic cost. Balkan military medical review. 1999; 2:139-141.
2. Epidemiology Working Group for NCIP Epidemic Response, ChCDCP. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China] [in Chinese] Zhonghua Liu Xing Bing Xue Za Zhi . 2020 Feb 10;41(2):145-151. [PubMed]
3. Boet S, Etherington C, Djaiani G, Tricco AC, Sikora L, Katznelson R. Efficacy and safety of hyperbaric oxygen treatment in SARS-COV-2 (COVID-19) pneumonia: a systematic review. Diving Hyperb Med. 2021 September 30;51(3):271-281. [PubMed]
4. Kjellberg A, Douglas J, Pawlik MT, Kraus M, Oscarsson N, Zheng X, et al. Randomized, controlled, open label, multicentre clinical trial to explore safety and efficacy of hyperbaric oxygen for preventing ICU admission, morbidity and mortality in adult patients with COVID-19. BMJ Open. 2021 Jul 5;11(7):e046738. [ PubMed ]
5. Oliaei S, SeyedAlinaghi S, Mehrtak M, Karimi A, Noori T, Mirzapour P, et al. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review. Eur J Med Res. 2021 Aug 19;26(1):96. [PubMed]
6. Boet S, Etherington C, Ghanmi N, Ioudovski P, Tricco AC, Sikora L, et al. Efficacy and safety of hyperbaric oxygen treatment to treat COVID-19 pneumonia: a living systematic review update. Diving Hyperb Med. 2022 June 30;52(2):126-135. [PubMed]
7. Senniappan K, Jeyabalan S, Rangappa P, Kanchi M. Hyperbaric oxygen therapy: Can it be a novel supportive therapy in COVID-19? Indian J Anaesth. 2020 Oct;64(10):835-841. [PubMed]
8. Turova EA, Shchikota AM, Pogonchenkova IV, Golovach AV, Tagirova DI, Gusakova EV.  [Hyperbaric oxygenation in outpatient rehabilitation of COVID-19 convalescents]. [in Russian] Vopr Kurortol Fizioter Lech Fiz Kult. 2021; 98(6):16-21. [PubMed]
9. Allam NM, Eladl HM, Eid MM. Hyperbaric oxygen therapy as a supportive therapy for COVID-19 patients: a narrative review. Eur Rev Med Pharmacol Sci. 2022 Aug;26(15):5618-5623. [PubMed]
10. Cannellotto M, Duarte M, Keller G, Larrea R, Cunto E, Chediack V, et al. Hyperbaric oxygen as an adjuvant treatment for patients with COVID-19 severe hypoxaemia: a randomized controlled trial. Emerg Med J. 2022 Feb;39(2):88-93. [PubMed]
11. Tobin MJ, Laghi F, Jubran A. Why COVID-19 Silent Hypoxemia Is Baffling to Physicians. Am J Respir Crit CareMed. 2020 Aug 1;202(3):356-360. [PubMed]
12. Bozov H. [Manual in marine medicine.] Military Medical Academy, Sofia. 2018. 456. [in Bulgarian]..

Received: 27 February 2023
Published online: 09 October 2023

back to Online Journal